UK markets closed

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2150+0.0060 (+2.87%)
At close: 04:00PM EDT
0.2153 +0.00 (+0.14%)
After hours: 06:10PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-12,565
-18,851
-15,274
-14,495
-9,458
Depreciation & amortisation
12.868
4.134
11.756
13.07
11.096
Stock-based compensation
1,230
1,007
1,203
1,724
1,293
Change in working capital
-169.953
3,699
3,164
-780.021
833.782
Accounts payable
-456.531
-
1,700
1,035
656.831
Other working capital
-11,496
-14,144
-10,562
-13,544
-7,336
Net cash provided by operating activities
-11,489
-14,140
-10,558
-13,538
-7,318
Cash flows from investing activities
Investments in property, plant and equipment
-6.499
-3.901
-4.422
-5.748
-17.945
Net cash used for investing activities
-6.499
-3.901
-4.422
-5.748
-17.945
Cash flows from financing activities
Debt repayment
-431.362
-438.733
-427.7
-477.49
-43.081
Common stock issued
10,626
2,318
16,038
4,654
14,222
Other financing activities
-202.859
-202.859
-
-
-45
Net cash used provided by (used for) financing activities
10,197
4,637
15,613
4,509
14,134
Net change in cash
-1,299
-9,507
5,051
-9,035
6,798
Cash at beginning of period
8,326
10,055
5,005
14,039
7,241
Cash at end of period
7,027
548.721
10,055
5,005
14,039
Free cash flow
Operating cash flow
-11,489
-14,140
-10,558
-13,538
-7,318
Capital expenditure
-6.499
-3.901
-4.422
-5.748
-17.945
Free cash flow
-11,496
-14,144
-10,562
-13,544
-7,336